A one-compartment model provides benchmark Lithium dose prediction.

Area of Science:

• Pharmacokinetics
• Pharmacology
• Clinical Pharmacy

Background:

• Lithium is crucial for treating recurrent affective disorders but has a narrow therapeutic window, necessitating careful serum concentration monitoring.
• Existing lithium dose prediction methods often lack accuracy and practical applicability, especially during dose adjustments.

Purpose of the Study:

• To develop an adaptable pharmacokinetic model for accurate lithium dose prediction in clinical settings.
• To create a user-friendly tool for initiating and optimizing lithium therapy.

Main Methods:

• A one-compartment pharmacokinetic model was developed, utilizing basic anthropometric data (age, sex, height, weight) to estimate lithium distribution in total body water.
• The model's predictive performance was evaluated against six established methods using independent patient cohorts from the UK and Germany.

Main Results:

• The developed one-compartment model demonstrated superior accuracy in predicting lithium carbonate doses compared to existing methods.
• The model achieved a mean prediction error of 10 mg (SD = 148 mg) in euthymic patients at steady state.

Conclusions:

• This novel model establishes a new standard for lithium dose prediction accuracy, requiring only simple patient measurements.
• Further validation in diverse populations and potential enhancements could facilitate widespread clinical adoption and improve patient management.